How to Help Your Patients Find Bupivacaine in Stock: A Provider's Guide

Updated:

March 28, 2026

Author:

Peter Daggett

Summarize this blog with AI:

A practical provider's guide to helping patients find Bupivacaine during the ongoing shortage. Sourcing strategies, alternatives, and workflow tips.

Your Patients Are Worried About the Bupivacaine Shortage — Here's How to Help

When patients learn that Bupivacaine is in shortage, anxiety often follows. Will their surgery be delayed? Is the alternative just as effective? Will it cost more? As a provider, you're in the best position to address these concerns — and to take practical steps that keep care on track.

This guide covers what you need to know about current Bupivacaine availability, why patients are struggling to find it, and five concrete actions you can take to help.

Current Availability: Where Things Stand

Bupivacaine Hydrochloride Injection has been in shortage since June 2023. As of early 2026:

  • Preservative-free formulations (critical for neuraxial use) remain the most constrained
  • 0.25% and 0.5% with preservative are intermittently available from select manufacturers
  • Bupivacaine with epinephrine has sporadic supply depending on distributor and region
  • Marcaine Spinal continues to face limited availability
  • FDA-imported Bupivacaine is available through some distributors — typically in ampule form

The shortage affects surgical centers, hospitals, dental practices, and pain management clinics nationwide. Supply varies significantly by geography and institutional purchasing relationships.

Why Patients Can't Find It

Understanding the patient perspective helps you communicate more effectively:

  • Bupivacaine is provider-administered — patients don't pick it up at a pharmacy. When their facility doesn't have it, they may feel helpless.
  • Procedures are being rescheduled. Some patients have had surgeries delayed multiple times due to anesthetic unavailability.
  • Information is confusing. Patients may read about the shortage online and not understand what it means for their specific procedure.
  • Alternative agents sound unfamiliar. Hearing that their provider will use a "substitute" can increase anxiety, especially for patients who researched Bupivacaine specifically.

Proactive communication goes a long way toward reducing patient stress and maintaining trust.

What Providers Can Do: 5 Practical Steps

Step 1: Confirm Supply Before Scheduling

Integrate anesthetic availability into your pre-surgical workflow. Before scheduling a procedure that relies on Bupivacaine:

  • Check with your pharmacy or materials management team on current stock
  • Confirm availability of both the primary agent and backup alternatives
  • Flag any procedures that specifically require preservative-free or spinal formulations

This prevents last-minute surprises and reduces the risk of day-of cancellations.

Step 2: Establish a Clear Substitution Protocol

Work with your pharmacy and therapeutics committee to create a Bupivacaine substitution algorithm. A well-designed protocol should address:

  • First-line substitute: Ropivacaine (Naropin) for most peripheral nerve blocks, epidurals, and infiltration
  • Second-line: Lidocaine for shorter procedures; Mepivacaine for intermediate-duration dental/peripheral blocks
  • Spinal anesthesia: If Bupivacaine spinal is unavailable, consider FDA-imported supply or Chloroprocaine for short cases
  • Postoperative pain: Exparel (liposomal Bupivacaine) for surgical site infiltration when extended analgesia is desired

Having a pre-approved protocol eliminates decision-making delays when supply shifts.

Step 3: Communicate Proactively with Patients

Don't wait for patients to ask. Include shortage communication in your standard pre-surgical process:

  • Mention anesthetic alternatives during pre-operative consultations
  • Explain that substitutes like Ropivacaine are well-established, widely used medications — not experimental choices
  • Share patient-friendly resources like Alternatives to Bupivacaine and Bupivacaine Shortage Update
  • Reassure patients that alternative agents have strong safety and efficacy profiles

Step 4: Diversify Your Supply Sources

Relying on a single distributor during a shortage is risky. Consider:

  • Multiple GPO contracts: Engage with McKesson, Cardinal Health, and AmerisourceBergen to compare availability
  • Specialty distributors: Some surgical supply companies maintain separate Bupivacaine inventory
  • FDA-authorized imports: Ask your distributor about imported Bupivacaine products that the FDA has authorized for temporary use
  • Compounding pharmacies: For select formulations, 503B outsourcing facilities may be able to compound Bupivacaine under cGMP conditions

Step 5: Use Medfinder for Providers

Medfinder for Providers is designed to help clinicians and facility managers locate medications in short supply. You can:

  • Search real-time Bupivacaine availability across pharmacies and facilities
  • Direct patients to nearby locations that have stock
  • Reduce procedure cancellations by identifying supply before scheduling

Alternatives: A Quick Reference

For detailed clinical guidance, see our provider shortage briefing. Here's a quick summary:

  • Ropivacaine: Long-acting, lower cardiotoxicity, FDA-approved for epidural/nerve block/infiltration. Primary substitute.
  • Lidocaine: Short-acting, widely available. Best for procedures under 2 hours.
  • Mepivacaine: Intermediate duration. Good for dental and shorter peripheral blocks.
  • Chloroprocaine: Ultra-short ester. Option for brief spinal anesthetics.
  • Exparel: Liposomal Bupivacaine for postsurgical pain. Up to 72 hours. $285–$365/vial.

Workflow Tips for Shortage Conditions

  • Audit your usage: Review which procedures consume the most Bupivacaine and prioritize conservation for those that benefit most from its specific properties.
  • Batch communications: Send a standardized shortage update to your surgical scheduling team, nursing staff, and CRNA group so everyone is aligned.
  • Track manufacturer updates: Subscribe to ASHP and FDA shortage alerts for real-time notifications on resupply dates.
  • Document substitutions: Maintain records of anesthetic substitutions for quality assurance and patient safety tracking.
  • Educate patients early: Include a shortage FAQ in your pre-surgical information packet.

Final Thoughts

The Bupivacaine shortage requires ongoing attention, but it doesn't have to derail your practice or your patients' care. By establishing clear substitution protocols, diversifying supply sources, communicating proactively, and leveraging tools like Medfinder, you can maintain care quality even in constrained supply conditions.

Related resources for your team and patients:

What's the best way to source Bupivacaine during the shortage?

Use multiple supply channels: your primary GPO, secondary distributors, specialty surgical suppliers, and FDA-authorized imported products. Register for ASHP and FDA shortage alerts. Medfinder for Providers (medfinder.com/providers) also helps locate available stock in your region.

Should I switch all cases to Ropivacaine during the shortage?

Ropivacaine is the most suitable broad substitute for most indications. However, it's not FDA-approved for intrathecal use in the U.S. For spinal anesthesia, you'll need to reserve available Bupivacaine spinal formulations or consider alternatives like Chloroprocaine for short cases. A tiered substitution protocol is recommended.

How do I explain the switch to patients who specifically requested Bupivacaine?

Emphasize that Ropivacaine is in the same drug class, has decades of clinical use, and is considered equally effective for most procedures — with an even better cardiac safety profile. Frame it as a medically appropriate substitution, not a downgrade. Sharing patient-friendly articles from Medfinder can help reinforce the message.

Can 503B compounding pharmacies make Bupivacaine?

Yes, FDA-registered 503B outsourcing facilities can compound Bupivacaine under current good manufacturing practice (cGMP) conditions. This can be a viable option for certain formulations, though availability, pricing, and lead times vary. Verify that the compounding pharmacy is FDA-registered and follows appropriate quality standards.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy